IFImmanuel Felix

Immanuel Felix

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Immanuel Felix has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Andry Setiadharma

    Division of Respirology and Critical Care, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia – Cipto Mangunkusumo Hospital, Jakarta, Indonesia

    1 shared publication
  • Arif Mansjoer

    Divisi Kardiologi Departemen Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Indonesia/RSUPN Dr. Cipto Mangunkusumo Jakarta

    1 shared publication
  • Calysta Nadya Wijaya

    Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia/Dr. Cipto Mangunkusumo National General Hospital, Jakarta 10430, Indonesia

    1 shared publication
  • Ceva Wicaksono Pitoyo

    Division of Respirology and Critical Care, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia – Cipto Mangunkusumo Hospital, Jakarta, Indonesia

    1 shared publication
  • Chee Kiang Tay

    Singapore General Hospital

    1 shared publication
  • Czeresna Heriawan Soejono

    Division of Geriatric Medicine, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia – Cipto Mangunkusumo Hospital, Jakarta, Indonesia

    1 shared publication

Latest Publications

  • Top Cited Papers
    Open Access

    The impact of body mass index on mortality in COPD: an updated dose–response meta-analysis

    by Eric Daniel Tenda, Joshua Henrina, Andry Setiadharma, Immanuel Felix, Mira Yulianti, Ceva Wicaksono Pitoyo, Sze Shyang Kho, Melvin Chee Kiang Tay, Dyah S. Purnamasari, Czeresna Heriawan Soejono, et al.

    Background and objective: The obesity paradox is a well-established clinical conundrum in COPD patients. This study aimed to provide an updated analysis of the relationship between body mass index (BMI) and mortality in this population.Methods: A systematic search was conducted through Embase, PubMed, and Web of Science. International BMI cut-offs were employed to define underweight, overweight and obesity. The primary outcome was all-cause mortality, and the secondary outcome was respiratory and cardiovascular mortality.Results: 120 studies encompassed a total of 1 053 272 patients. Underweight status was associated with an increased risk of mortality, while overweight and obesity were linked to a reduced risk of mortality. A nonlinear U-shaped relationship was observed between BMI and all-cause mortality, respiratory mortality and cardiovascular mortality. Notably, an inflection point was identified at BMI 28.75 kg·m−2(relative risk 0.83, 95% CI 0.80–0.86), 30.25 kg·m−2(relative risk 0.51, 95% CI 0.40–0.65) and 27.5 kg·m−2(relative risk 0.76, 95% CI 0.64–0.91) for all-cause, respiratory and cardiovascular mortality, respectively, and beyond which the protective effect began to diminish.Conclusion: This study augments the existing body of evidence by confirming a U-shaped relationship between BMI and mortality in COPD patients. It underscores the heightened influence of BMI on respiratory and cardiovascular mortality compared to all-cause mortality. The protective effect of BMI was lost when BMI values exceeded 35.25 kg·m−2, 35 kg·m−2and 31 kg·m−2for all-cause, respiratory and cardiovascular mortality, respectively.


  • Open Access

    Obesity Parameters as Predictor of Poor Outcomes in Hospitalized Patients with Confirmed Mild-to-Moderate COVID-19

    by Nadya R. V. Barus, Dicky Levenus Tahapary, Farid Kurniawan, Robert Sinto, Syahidatul Wafa, Wismandari Wisnu, Arif Mansjoer, Calysta Nadya Wijaya, Immanuel Felix, Tri Juli Edi Tarigan, et al.

    (1) Background: This study aims to assess visceral fat values, waist circumference (WC), body mass index (BMI), and body fat percentage for their ability to predict poor outcomes during COVID-19 patients’ hospitalization; (2) Methods: This study was a prospective cohort of mild–moderate COVID-19 patients hospitalized at Dr. Cipto Mangunkusumo National General Hospital from December 2020 to March 2021. This study includes hospitalized patients over 18 diagnosed with COVID-19 using RT-PCR. Patients who do not have chest radiography, waist circumference, a bioimpedance analyzer (BIA) error, or are unable to stand or mobilize during the examination are excluded from this study. Cox regression was used for multivariate analysis; (3) Results: The study included two hundred sixty-one patients. The median visceral fat value was 10 (equivalent to 100 cm2), the WC was 93.4 cm, the BMI was 26.1 kg/m2, and the body fat percentage was 31.5%. Based on multivariate Cox regression, WC was statistically significant as an independent factor influencing poor outcomes in COVID-19 patients (RR 1.037 [95% CI 1.011–1.064]) along with COVID-19 degree of severity (RR 3.063 [95% CI 1.537–6.104]) and comorbidities (RR 2.123 [95% CI 1.017–4.435]); (4) Conclusions: Waist circumference can influence poor outcomes in confirmed COVID-19 patients during hospitalization.